Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Dallas Group of America is a global manufacturer specializing in synthetic magnesium silicates and specialty adsorbents used across the pharmaceutical, food, and chemical sectors. The company provides high-performance purification media, such as MAGNESOL and DALSORB, which are essential for removing impurities during the production of active pharmaceutical ingredients (APIs) and edible oils. Their products support downstream processing and filtration in life science manufacturing, ensuring product purity and compliance with regulatory standards. Headquartered in New Jersey, the company operates several manufacturing sites and maintains a strong focus on technical innovation in separation science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Dallas Group of America.